<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 28.7: Polypharmacy and the Microbiome: Managing Drug-Nutrient-Microbe Interactions</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1a5d48;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 600;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e5e5;
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f1f8f6;
            color: #059669;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #10B981;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #f0fdf4;
            border: 1px dashed #10B981;
            padding: 20px;
            border-radius: 12px;
            margin: 25px 0;
            display: flex;
            align-items: center;
            gap: 20px;
        }

        .stat-value {
            font-size: 32px;
            font-weight: 800;
            color: #059669;
            flex-shrink: 0;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            margin-top: 15px;
            font-size: 15px;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            border-left: 6px solid #059669;
        }

        .references-box {
            background: #f9f9f9;
            padding: 30px;
            border-radius: 14px;
            font-size: 14px;
            color: #555;
            margin-top: 50px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 28: L3: Crisis & Complex Cases</p>
            <h1 class="lesson-title">Lesson 7: Polypharmacy and the Microbiome: Managing Drug-Nutrient-Microbe Interactions</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Advanced Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Medication-Microbiome Loop</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Pharmacomicrobiomics & P450</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Advanced Antibiotic Stewardship</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Drug-Nutrient Depletion Matrix</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Supplement-Drug Contraindications</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The Deprescribing Advocacy Protocol</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze how common non-antibiotic medications (PPIs, NSAIDs, Metformin) induce complex dysbiosis.</li>
                <li>Explain the mechanism of microbial xenometabolism and its impact on drug toxicity and efficacy.</li>
                <li>Design advanced "during and after" antibiotic protocols for long-term or recurrent users.</li>
                <li>Identify critical supplement-drug contraindications that could compromise client safety.</li>
                <li>Develop a collaborative strategy for supporting clients through medically-supervised deprescribing.</li>
            </ul>
        </div>

        <p>In the world of complex gut health coaching, we rarely encounter a "clean slate." Most clients presenting with chronic GI dysfunction are already navigating <span class="highlight">polypharmacy</span>‚Äîthe concurrent use of five or more medications. While these drugs may be necessary for managing systemic conditions, they often create a "chemical weather" in the gut that thwarts even the most well-designed nutritional protocols.</p>

        <div class="stat-highlight">
            <div class="stat-value">24%</div>
            <div>A 2018 landmark study in <i>Nature</i> screened 1,197 drugs and found that 24% of non-antibiotic medications (including antipsychotics and PPIs) inhibited the growth of at least one human gut bacterial strain.</div>
        </div>

        <h2 id="section1">1. The Medication-Microbiome Loop</h2>
        <p>The relationship between medication and the microbiome is bidirectional: drugs alter the microbial community, and the microbial community alters the drugs. This creates a loop that can lead to "treatment-resistant" symptoms.</p>

        <h3>Proton Pump Inhibitors (PPIs)</h3>
        <p>PPIs are among the most frequently prescribed drugs worldwide. By raising gastric pH, they dismantle the "acid barrier," allowing oral and upper respiratory bacteria to migrate to the lower GI tract. This leads to a significant increase in <span class="highlight">Streptococcus</span> and <span class="highlight">Actinomyces</span> species in the colon, a pattern highly associated with SIBO and increased risk of <i>C. difficile</i> infection.</p>

        <h3>NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)</h3>
        <p>NSAIDs like ibuprofen and naproxen don't just "irritate" the lining; they actively alter the microbiome to favor pro-inflammatory Proteobacteria. This shift compromises the <span class="highlight">mucosal barrier</span>, leading to NSAID-induced enteropathy, which often presents as unexplained iron-deficiency anemia or chronic bloating.</p>

        <h3>Metformin</h3>
        <p>While Metformin is celebrated for increasing <i>Akkermansia muciniphila</i> and improving insulin sensitivity, it also increases the abundance of <i>Escherichia/Shigella</i>. For many clients, this microbial shift is the primary driver of the GI distress (diarrhea, cramping) that often leads to Metformin non-compliance.</p>

        <h2 id="section2">2. Pharmacomicrobiomics & Cytochrome P450</h2>
        <p>We have long known that the liver's <span class="highlight">Cytochrome P450 (CYP450)</span> enzyme system is responsible for drug metabolism. However, the emerging field of <strong>pharmacomicrobiomics</strong> reveals that gut microbes often perform the <i>first</i> step of metabolism before a drug even reaches the liver.</p>

        <p>Microbes produce enzymes that can activate a pro-drug, inactivate an active drug, or‚Äîmost dangerously‚Äîconvert a drug into a toxic metabolite. For example:</p>
        <ul>
            <li><strong>Digoxin:</strong> The bacteria <i>Eggerthella lenta</i> can metabolize digoxin into an inactive form, requiring some patients to take much higher doses to achieve cardiac effects. If a coach then uses antibiotics or specific prebiotics that reduce <i>E. lenta</i>, digoxin levels could spike to toxic levels.</li>
            <li><strong>Levodopa (Parkinson‚Äôs):</strong> Microbial decarboxylases in the gut can convert Levodopa to dopamine before it crosses the blood-brain barrier, reducing its efficacy and causing peripheral side effects.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üìã</div>
                <div>
                    <p class="box-label">Case Study: The PPI-SIBO Spiral</p>
                    <p class="subtitle">Client: Elena, 54 | Presenting: Chronic Bloating & Brain Fog</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Patient Profile</h4>
                        <p>History of GERD (10 years on Omeprazole), Type 2 Diabetes (Metformin), and Osteoarthritis (daily Ibuprofen).</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Elena‚Äôs "The Method" assessment revealed high microbial diversity but a massive overrepresentation of oral-origin bacteria (<i>Streptococcus salivarius</i>) in her stool. Her bloating was unresponsive to standard low-FODMAP protocols.</p>
                <p><strong>Outcome:</strong> By working with her GP to transition from daily PPIs to H2 blockers and eventually a "wean-off" protocol (using DGL and Zinc Carnosine), and switching her NSAIDs to Boswellia/Turmeric, her SIBO symptoms resolved within 12 weeks. The "chemical weather" had to be cleared before the microbiome could stabilize.</p>
            </div>
        </div>

        <h2 id="section3">3. Advanced Antibiotic Stewardship</h2>
        <p>As gut health coaches, we do not advise against medically necessary antibiotics. Instead, we provide a "Microbial Shield" protocol. The traditional advice of "wait until the course is finished to take probiotics" is now considered outdated for most cases.</p>

        <h3>The "During" Protocol</h3>
        <p>To mitigate damage during a 7‚Äì14 day course of antibiotics:</p>
        <ul>
            <li><strong>Saccharomyces boulardii:</strong> This probiotic yeast is naturally resistant to antibiotics. A 2022 meta-analysis confirmed its efficacy in reducing Antibiotic-Associated Diarrhea (AAD) by 53%. Dose: 500mg twice daily, taken 2 hours away from the antibiotic.</li>
            <li><strong>Lactobacillus rhamnosus GG (LGG):</strong> One of the most researched strains for preventing the overgrowth of opportunistic pathogens during treatment.</li>
            <li><strong>Soluble Fiber (PHGG):</strong> Partially Hydrolyzed Guar Gum (5g/day) can act as a "decoy" and fuel for commensal bacteria, helping them survive the antibiotic "firestorm."</li>
        </ul>

        <h3>The "After" Protocol (3-6 Months)</h3>
        <p>Recovery is not immediate. Research shows that while the microbiome "recovers" its biomass quickly, specific foundational species (like <i>Faecalibacterium prausnitzii</i>) may remain depleted for up to 6 months. High-dose multi-strain probiotics should be followed by a heavy emphasis on <span class="highlight">polyphenols</span> (pomegranate, green tea, cocoa) to stimulate the regrowth of keystone species.</p>

        <h2 id="section4">4. Drug-Nutrient-Microbe Depletion Matrix</h2>
        <p>Understanding these interactions allows the coach to identify why a client might be struggling with fatigue, mood issues, or poor healing despite a "clean" diet.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Medication Class</th>
                        <th>Nutrient Depletions</th>
                        <th>Microbial Impact</th>
                        <th>Coaching Consideration</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>PPIs (Omeprazole)</strong></td>
                        <td>B12, Magnesium, Iron, Zinc, Calcium</td>
                        <td>Reduced diversity; ‚Üë Oral bacteria migration</td>
                        <td>Monitor for hypochlorhydria; suggest liquid B12</td>
                    </tr>
                    <tr>
                        <td><strong>Metformin</strong></td>
                        <td>Vitamin B12, Folate</td>
                        <td>‚Üë <i>Akkermansia</i>; ‚Üë <i>Shigella</i></td>
                        <td>B12 levels must be checked annually; use ginger for GI upset</td>
                    </tr>
                    <tr>
                        <td><strong>Statins</strong></td>
                        <td>CoQ10, Vitamin D</td>
                        <td>‚Üì <i>Bacteroides</i>; ‚Üì SCFA production</td>
                        <td>CoQ10 supplementation (200mg+) often necessary for muscle aches</td>
                    </tr>
                    <tr>
                        <td><strong>Oral Contraceptive</strong></td>
                        <td>B6, B12, Folate, Zinc, Magnesium</td>
                        <td>‚Üë Intestinal permeability; altered Estrobolome</td>
                        <td>Focus on cruciferous vegetables for estrogen metabolism</td>
                    </tr>
                    <tr>
                        <td><strong>SSRIs</strong></td>
                        <td>Melatonin, Folate</td>
                        <td>Altered serotonin signaling; ‚Üì <i>Turicibacter</i></td>
                        <td>Watch for changes in transit time (constipation/diarrhea)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section5">5. Supplement-Drug Contraindications</h2>
        <p>This is the most critical area for practitioner liability. Many "natural" gut supplements are potent modulators of the CYP450 system.</p>

        <div class="principle-card">
            <div class="principle-title">Critical Contraindication: Berberine</div>
            <p class="principle-text">Berberine is widely used for SIBO and blood sugar. However, it is a potent inhibitor of <span class="highlight">CYP3A4</span>. This enzyme metabolizes over 50% of all pharmaceutical drugs. Taking Berberine alongside Statins, Calcium Channel Blockers, or certain Clarithromycin can lead to dangerously high blood levels of these medications.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Critical Contraindication: St. John's Wort</div>
            <p class="principle-text">Often used for the "Gut-Brain" connection in depression. It is a potent <i>inducer</i> of CYP3A4, meaning it speeds up the breakdown of drugs. It can render birth control pills, anticoagulants (Warfarin), and anti-rejection meds completely ineffective.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Critical Contraindication: Grapefruit Seed Extract (GSE)</div>
            <p class="principle-text">Similar to whole grapefruit, GSE inhibits the 1A2 and 3A4 pathways. If a client is on cardiac medication, GSE is strictly contraindicated due to the risk of arrhythmia or toxicity.</p>
        </div>

        <h2 id="section6">6. The Deprescribing Advocacy Protocol</h2>
        <p>Clients often come to a gut coach because they want to "get off their meds." It is outside our scope of practice to tell a client to stop a medication. However, we can be <strong>advocates for clinical re-evaluation</strong>.</p>

        <p>The <strong>AccrediPro Deprescribing Support Framework</strong> involves:</p>
        <ol class="content-list">
            <li><strong>Objective Data Collection:</strong> Use "The Method" to document symptom improvements as gut function is restored (e.g., "Client now reports 0/10 heartburn after meals").</li>
            <li><strong>The "Physician Letter":</strong> Provide the client with a structured summary of their progress and a list of evidence-based concerns (e.g., "Long-term PPI use is associated with B12 deficiency and SIBO; client has now addressed underlying digestive triggers").</li>
            <li><strong>Bridge Support:</strong> When a doctor initiates a taper, the coach provides the "bridge" nutrients (e.g., using marshmallow root and slippery elm during a PPI taper to prevent rebound acid hypersecretion).</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why does long-term PPI use often lead to a SIBO-like symptom profile even if the client's diet is "perfect"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">PPIs raise gastric pH, which removes the "acid barrier." This allows oral bacteria (which are usually killed by stomach acid) to survive and migrate to the small and large intestine, where they cause dysbiosis and fermentation of otherwise healthy foods.</div>
            </div>
            <div class="question-item">
                <p class="question-text">2. A client is taking Berberine for SIBO and starts a new medication for high blood pressure. What is the primary concern?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Berberine inhibits the CYP3A4 enzyme. Since many blood pressure medications (like calcium channel blockers) are metabolized by this enzyme, the Berberine may cause the drug levels to rise to toxic levels, potentially causing dangerously low blood pressure or other side effects.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>The 24% Rule:</strong> Nearly a quarter of non-antibiotic drugs have antibiotic-like effects on the microbiome.</li>
                <li><strong>pH Matters:</strong> PPIs are a primary driver of complex dysbiosis by allowing oral-to-gut bacterial translocation.</li>
                <li><strong>Pharmacomicrobiomics:</strong> The microbiome is the "first pass" of drug metabolism; changes in gut bugs can change drug safety.</li>
                <li><strong>Safety First:</strong> Always cross-reference gut supplements (especially Berberine and GSE) with the client's medication list using a database like Medscape or Drugs.com.</li>
                <li><strong>Collaborative Care:</strong> We don't deprescribe; we provide the clinical evidence and nutritional support that makes deprescribing possible for the MD.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Maier et al. (2018). "Extensive impact of non-antibiotic drugs on human gut bacteria." Nature.</li>
                <li>Jackson et al. (2016). "Proton pump inhibitors alter the composition of the gut microbiota." Gut.</li>
                <li>Weersma et al. (2020). "Interaction between drugs and the gut microbiome." Gut.</li>
                <li>Koppel et al. (2017). "Chemical tricks of the trade: Enzymatic strategies of the gut microbiota for drug metabolism." Current Opinion in Chemical Biology.</li>
                <li>Zimmermann et al. (2019). "Mapping human microbiome drug metabolism by gut bacteria and their genes." Nature.</li>
                <li>Suez et al. (2018). "Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT." Cell.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Gut Health & Microbiome Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>